References
- Lippe B. Turner syndrome. Endocrinol Metab Clin North Am 1991;20:121–52
- Saenger P. The current status of diagnosis and thera-peutic intervention in Turner's syndrome. J Clin Endocrinol Metab 1993;77:297–301
- Landin-Wilhelmsen K, Bryman I, Windh M, et al. Osteoporosis and fractures in Turner syndrome: importance of growth promoting and oestrogen therapy. Clin Endocrinol 1999;51:497–502
- Chiodini I, Trischitta V, Carnevale V, et al. Bone mineral density in acromegaly: does growth hor-mone excess protect against osteoporosis? JEndocrino/ Invest 2001;24:288–91
- Neely EK, Marcus R, Rosenfeld RG, et al. Turner syndrome adolescents receiving growth hormone are not osteopenic. J Clin Endocrinol Metab 1993; 76:861–6
- Sylven L, Hagenfeldt K, Ringertz H. Bone mineral density in middle-aged women with Turner's syn-drome. Eur J Endocrinol 1995;132:47–52
- Bolanowski M, Wielgus W, Milewicz A, et al. Axial bone mineral density in patients with acromegaly. Acad Radio/ 2000;7:592–4
- Bouillon R, Prodonova A. Growth hormone deficiency and peak bone mass. J Pediatr Endocrinol Metab 2000;13:1327–36
- Colao A, Baldelli R, Marzullo P, et al. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acro-megalic cardiomyopathy. J Clin Endocrinol Metab 2000;85:193–9